EMONO for the Treatment of Peripheral Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Neuralgia
Interventions
DRUG

Medical Air

DRUG

EMONO

Trial Locations (22)

13385

CHU la Timone, Marseille

14401

Centre Hospitalier de Bayeux, Bayeux

25030

Centre Hospitalier Regional Universitaire - Hôpital Jean-Minjoz, Besançon

30029

Hôpital Universitaire Caremeau, Nîmes

33000

Hôpital Pellegrin, Bordeaux

34295

Hôpital Saint Eloi, Montpellier

38700

CHU de Grenoble, Grenoble

44046

Clinique Brétéché, Nantes

44093

Hôpital Nord Laennec, Nantes

44202

Nouvelles Cliniques Nantaises, Nantes

57530

Centre Hospitalier Régional de Metz-Thionville, Metz-Thionville

63003

Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand

69677

Hopital Neurologique Weirthermer, Bron

69800

Clinique IRIS Saint-Priest, Saint-Priest

75010

Hôpital Lariboisière, Paris

75014

Hôpital Cochin, Paris

76000

Centre hospitalier Universitaire de Rouen, Rouen

81675

Neurologische Klinik Klinikum rechts der Isar, München

87042

Centre Hospitalier Universitaire Dupuytren, Limoges

92100

Hôpital Ambroise Paré, Boulogne-Billancourt

93350

Clinique du Bourget, Le Bourget

97080

Neurologische Klinik Universitätsklinikum, Würzburg

All Listed Sponsors
collaborator

AMS Advanced Medical Services GmbH

INDUSTRY

lead

Air Liquide Santé International

INDUSTRY

NCT02957851 - EMONO for the Treatment of Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter